Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Malignant Melanoma

  Free Subscription


Articles published in Anticancer Res

Retrieve available abstracts of 50 articles:
HTML format



Single Articles


    March 2024
  1. FERNANDO PDSM, Zhen AX, Piao MJ, Herath HMUL, et al
    Naringenin Induces Cellular Apoptosis in Melanoma Cells via Intracellular ROS Generation.
    Anticancer Res. 2024;44:1079-1086.
    PubMed     Abstract available


    February 2024
  2. POPP K, Popp R, Bansal S, Sharan S, et al
    Disparities in Time-to-treatment for Patients With Melanoma.
    Anticancer Res. 2024;44:631-637.
    PubMed     Abstract available


  3. SCALIA G, Silven MP, Costanzo R, Porzio M, et al
    Intraventricular Cerebral Metastases: A Comprehensive Systematic Review.
    Anticancer Res. 2024;44:453-462.
    PubMed     Abstract available


    January 2024
  4. CESAR MCM, Mortara RA, Souza VS, Alves VRG, et al
    Peptide L13S Derived from the BRN2 POU Domain Reduces Metastasis In Vivo and Inhibits Cell Migration and Invasion In Vitro.
    Anticancer Res. 2024;44:71-84.
    PubMed     Abstract available


  5. WALZ SN, Martineau J, Scampa M, Madduri S, et al
    Incidence Trends of Melanoma of the Lower Limbs and Hips in the United States: A Surveillance, Epidemiology, and End Results Analysis 2000-2019.
    Anticancer Res. 2024;44:239-247.
    PubMed     Abstract available


  6. KELEMEN G, Egyud Z, Dobi A, Varga L, et al
    Survival Benefit of Stereotactic Radiotherapy in the Complex Management of Metastatic Melanoma.
    Anticancer Res. 2024;44:205-212.
    PubMed     Abstract available


    October 2023
  7. GLASER N, Petzold A, Wessely A, Kaufmann MD, et al
    Threshold Optimization for Tumor Markers S100b and MIA in Uveal Melanoma - A Single Center Analysis.
    Anticancer Res. 2023;43:4525-4532.
    PubMed     Abstract available


  8. TASSAVOR M, Martin BJ, Glazer AM
    The Integrated i31-GEP Test Outperforms the MSKCC Nomogram at Predicting SLN Status in Melanoma Patients.
    Anticancer Res. 2023;43:4511-4516.
    PubMed     Abstract available


  9. DURZYNSKA M, Dos Santos FLC, Matuszczyk A, Derezinska-Wolek E, et al
    Prognostic Implications of PRAME Expression and Clinicopathological Factors in Sinonasal Mucosal Melanoma: A Single-center Cohort Study of 30 Cases.
    Anticancer Res. 2023;43:4551-4557.
    PubMed     Abstract available


    September 2023
  10. WALZ SN, Martineau J, Scampa M, Madduri S, et al
    Melanoma of the Lower Limbs and Hips: A Surveillance, Epidemiology, and End Results Analysis of Epidemiology and Survival 2000-2019.
    Anticancer Res. 2023;43:4105-4113.
    PubMed     Abstract available


    August 2023
  11. KIM Y, Kim JE, Lee DY, Choi JU, et al
    T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against HVEM-over-expressing Melanoma Cell Lines.
    Anticancer Res. 2023;43:3419-3427.
    PubMed     Abstract available


    June 2023
  12. WANG CH, Wang LK, Wu CC, Chen ML, et al
    TIG1 Inhibits the mTOR Signaling Pathway in Malignant Melanoma Through the VAC14 Protein.
    Anticancer Res. 2023;43:2635-2643.
    PubMed     Abstract available


  13. HIPPNER-KUNICKA M, Laszkiewicz A, Skrzymowska J, Biecek P, et al
    Overexpression of c-MYC Promoter Binding Protein-1 Enhances Proliferation and Glucose Metabolism of Melanoma Cells Lines.
    Anticancer Res. 2023;43:2527-2538.
    PubMed     Abstract available


    April 2023
  14. FRIEDLANDER P, Morgan LR, Benes EN, Rodgers AH, et al
    Preclinical Activity of 4-Demethyl-4-cholesteryloxycarbonylpenclomedine in Melanoma.
    Anticancer Res. 2023;43:1407-1413.
    PubMed     Abstract available


  15. GRUJIC M, Nguyen T, Hechard T, Wang H, et al
    Phenotypic Switch and Growth of Melanoma Spheroids in the Presence of Mast Cells: Potential Impact of Nutrient-starvation Effects.
    Anticancer Res. 2023;43:1415-1426.
    PubMed     Abstract available


  16. JARELL A, Fernandes N
    Letter to the Editor: RE: de Gruijl and Armstrong: Cutaneous Melanoma: Sheep in Wolves Clothing? Anticancer Res 42(10): 5021-5025, 2022.
    Anticancer Res. 2023;43:1873-1874.
    PubMed    


  17. SASAKI K, Hirohashi Y, Murata K, Minowa T, et al
    SOX10 Inhibits T Cell Recognition by Inducing Expression of the Immune Checkpoint Molecule PD-L1 in A375 Melanoma Cells.
    Anticancer Res. 2023;43:1477-1484.
    PubMed     Abstract available


    March 2023
  18. POOMMARAPAN K, Rummaneethorn P, Srisubat A, Suwanpidokkul N, et al
    Gene Profiling of Cannabis-sativa-mediated Apoptosis in Human Melanoma Cells.
    Anticancer Res. 2023;43:1221-1237.
    PubMed     Abstract available


    February 2023
  19. PLANSKA D, Horak V
    Spontaneous Regression of Swine Melanoma: The Role of Tumour-infiltrating T and NK Cells.
    Anticancer Res. 2023;43:631-638.
    PubMed     Abstract available


  20. BAGHERI MS, Polivka J, Treskova I, Houfkova K, et al
    Preoperative Plasma miRNA Levels Predict Prognosis in Early-stage Malignant Melanoma.
    Anticancer Res. 2023;43:695-706.
    PubMed     Abstract available


    January 2023
  21. SUCKOW MA, Hiles MC
    Use of Conditioned Extracellular Matrix as a Tissue-engineered Tumor Matrisome for Prostate Cancer and Melanoma Immunotherapy.
    Anticancer Res. 2023;43:335-341.
    PubMed     Abstract available


  22. FUJII N, Yashiro M, Hatano T, Fujikawa H, et al
    CD9-positive Exosomes Derived from Cancer-associated Fibroblasts Might Inhibit the Proliferation of Malignant Melanoma Cells.
    Anticancer Res. 2023;43:25-33.
    PubMed     Abstract available


    December 2022
  23. MORI M, Saito K, Sekine A, Hasebe R, et al
    Endosomal Localization of RacGAP Protein ARHGAP22 Regulates its GAP Activity in Human Melanoma Cells.
    Anticancer Res. 2022;42:5763-5771.
    PubMed     Abstract available


  24. NOVAK P, Balakin A, Temnik M
    In Vitro Anticancer Activity of the Light Stable Zinc Isotope ((64)Zn) Compounds.
    Anticancer Res. 2022;42:5685-5698.
    PubMed     Abstract available


    November 2022
  25. ISHIGURO M, Fukushige T, Iwasaki H, Hamasaki M, et al
    Establishment and Characterisation of Human Clear Cell Sarcoma and Malignant Melanoma Cell Lines.
    Anticancer Res. 2022;42:5315-5322.
    PubMed     Abstract available


  26. HEINO P, Myllari P, Jahkola T, Luoma ML, et al
    Surgery, Limb Edema and Health-related Quality of Life: A Prospective Follow-up Study on Patients With Cutaneous Malignant Melanoma.
    Anticancer Res. 2022;42:5507-5519.
    PubMed     Abstract available


  27. KIM NH, An JH, Lee JH, Park SM, et al
    Effects of Cyclooxygenase-2 in Canine Melanoma-derived Extracellular Vesicles on Tumor Microenvironment In Vitro.
    Anticancer Res. 2022;42:5397-5405.
    PubMed     Abstract available


    October 2022
  28. DAMEN PJJ, Suijkerbuijk KPM, VAN Lindert ASR, Eppinga WSC, et al
    Long-term Local Control and Overall Survival After Radiotherapy in Oligoprogressive Patients During Treatment With Checkpoint Inhibitors.
    Anticancer Res. 2022;42:4795-4804.
    PubMed     Abstract available


  29. DE GRUIJL FR, Armstrong BK
    Cutaneous Melanoma: Sheep in Wolves Clothing?
    Anticancer Res. 2022;42:5021-5025.
    PubMed     Abstract available


    July 2022
  30. LAI ZY, Li DY, Huang CY, Tung KC, et al
    Valproic Acid Enhances Radiosensitization via DNA Double-strand Breaks for Boronophenylalanine-mediated Neutron Capture Therapy in Melanoma Cells.
    Anticancer Res. 2022;42:3413-3426.
    PubMed     Abstract available


    June 2022
  31. NII T, Yoshikawa K, Takeuchi I, Makino K, et al
    Preparation of Micelles Encapsulating Doxorubicin and Their Anticancer Effect in Combination With Tranilast in 3D Spheroids and In Vivo.
    Anticancer Res. 2022;42:2847-2857.
    PubMed     Abstract available


  32. POUDEL M, Kim G, Bhattarai PY, Shin S, et al
    Potent Imidazothiazole-based Inhibitor of BRAF V600E Overcomes Acquired Resistance via Inhibition of RAF Dimerization in PLX4032-resistant Melanoma.
    Anticancer Res. 2022;42:2911-2921.
    PubMed     Abstract available


    April 2022
  33. LALISCIA C, Genovesi-Ebert F, Perrone F, Guido F, et al
    Photon-based High-dose Single-fraction Radiosurgery, an Effective Treatment Modality for Large and Posterior Uveal Melanoma.
    Anticancer Res. 2022;42:1965-1972.
    PubMed     Abstract available


    March 2022
  34. BARAK V, Kalickman I, Pe'er J
    sIL-2R- an Immuno-biomarker for Prediction of Metastases in Uveal Melanoma.
    Anticancer Res. 2022;42:1447-1453.
    PubMed     Abstract available


    February 2022
  35. ITA MI, Wang JH, Heffron CC, Power DG, et al
    Therapeutic Response Evaluation in Advanced Melanoma Patients Incorporating Plasma cfDNA, LDH, VEGF, PD-L1, and IFN-gamma Measurements.
    Anticancer Res. 2022;42:801-810.
    PubMed     Abstract available


    January 2022
  36. YONEKURA S
    Epstein-Barr Virus-induced Gene 3 as a Novel Biomarker in Metastatic Melanoma With Infiltrating CD8(+) T Cells: A Study Based on The Cancer Genome Atlas (TCGA).
    Anticancer Res. 2022;42:511-517.
    PubMed     Abstract available


    December 2021
  37. LIN SJ, Huang YC, Chen HY, Fang JY, et al
    RGS2 Suppresses Melanoma Growth via Inhibiting MAPK and AKT Signaling Pathways.
    Anticancer Res. 2021;41:6135-6145.
    PubMed     Abstract available


  38. USHIJIMA H, Monzaki R, Onodera A
    Suppressive Effects of Anisomycin on the Proliferation of B16 Mouse Melanoma Cells In Vitro.
    Anticancer Res. 2021;41:6113-6121.
    PubMed     Abstract available


  39. KOU L, Zhu Z, Fajardo E, Bai Q, et al
    Harnessing the Power of Kiwifruit for Radiosensitization of Melanoma.
    Anticancer Res. 2021;41:5945-5951.
    PubMed     Abstract available


    August 2021
  40. MAEDA C, Iizuka A, Miyata H, Kondou R, et al
    Alternative Evaluation of an ELISPOT Assay Using Cytokine Activity as a Novel Parameter.
    Anticancer Res. 2021;41:3825-3831.
    PubMed     Abstract available


    June 2021
  41. DEBICKA-KUMELA M, Romanowska-Dixon B, Karska-Basta I, Kowal J, et al
    Diagnostic Algorithm for Conjunctival Melanocytic Lesions.
    Anticancer Res. 2021;41:3161-3167.
    PubMed     Abstract available


    May 2021
  42. KANG BS, Lim SC
    Fascin Regulates the Hippo Pathway and Is Important for Melanoma Development.
    Anticancer Res. 2021;41:2403-2410.
    PubMed     Abstract available


    April 2021
  43. BOCZAR D, Bagaria SP, Spaulding AC, Huayllani MT, et al
    Treatment Contraindications Based on Comorbidity Status in Patients With Melanoma in the United States.
    Anticancer Res. 2021;41:2067-2070.
    PubMed     Abstract available


    March 2021
  44. LEE Y, Park D
    Effect of Metformin in Combination With Trametinib and Paclitaxel on Cell Survival and Metastasis in Melanoma Cells.
    Anticancer Res. 2021;41:1387-1399.
    PubMed     Abstract available


    February 2021
  45. EGGER EK, Stope MB, Recker F, Konsgen D, et al
    Lower Genital Tract Melanomas: Staging, Predictors of Outcome, and New Therapeutic Options.
    Anticancer Res. 2021;41:999-1004.
    PubMed     Abstract available


  46. BADAKHSHI H, Wang ZM, Li RJ, Ismail M, et al
    Survival and Prognostic Nomogram for Primary Gastrointestinal Melanoma (PGIM): A Population-based Study.
    Anticancer Res. 2021;41:967-974.
    PubMed     Abstract available


  47. LEE KM, An JH, Yang SJ, Park SM, et al
    Influence of Canine Macrophage-derived Extracellular Vesicles on Apoptosis in Canine Melanoma and Osteosarcoma Cell Lines.
    Anticancer Res. 2021;41:719-730.
    PubMed     Abstract available


  48. DEBICKA-KUMELA M, Romanowska-Dixon B, Karska-Basta I, Kowal J, et al
    The Evaluation of the Malignant Characteristics of Conjunctival Lesions Based on the Dermatoscopic Algorithm.
    Anticancer Res. 2021;41:895-903.
    PubMed     Abstract available


    January 2021
  49. MARKIEWICZ A, Donizy P, Elas M, OrLowska-Heitzmann J, et al
    Nuclear Pseudoinclusions and Intranuclear Grooves Have an Important Impact on the Long-term Survival of Patients With Uveal Melanoma.
    Anticancer Res. 2021;41:517-526.
    PubMed     Abstract available


    November 2020
  50. BORGOGNONI L, Pescitelli L, Gerlini G, Brandani P, et al
    Efficacy of Electrochemotherapy in the Treatment of Cutaneous Melanoma Metastases and Rare Non-melanoma Skin Cancer.
    Anticancer Res. 2020;40:6485-6492.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Malignant Melanoma is free of charge.